The Leadership Team at First Ascent Biomedical guides the strategic direction of the company, focusing on the development and implementation of personalized cancer therapies through innovative machine learning and AI technologies. Comprising the CEO, CTO, and CRO, the team collaborates to oversee R&D initiatives, ensure regulatory compliance, and build partnerships, all aimed at optimizing cancer drug combinations for improved patient outcomes.
View all